Marvell Stock Rallies 45% In Month, UBS Lifts Target To $340
MRVL•Marvell stock surged 45% over the past month and trades at roughly 68.6 times this year's expected earnings. UBS raised its price target from $230 to $340, citing potential for $1 billion in CXL revenue by 2027 and $2 billion by 2028 alongside annual revenue growth forecasts near 40.8%.
1. Stock Performance Surge
Marvell shares have climbed 45% over the last month, marking one of the strongest monthly gains among semiconductor providers as data center demand accelerates.
2. Valuation and Growth Outlook
The stock now trades at about 68.6 times this fiscal year's projected earnings, but based on analysts' 2029 forecasts the multiple falls to roughly 31.0, reflecting expectations of 40.8% annual revenue growth driven by AI and data center expansion.
3. UBS Price Target Upgrade
UBS maintained its Buy rating and increased its price target from $230 to $340, projecting $1 billion in Compute Express Link (CXL) revenue by 2027 and $2 billion by 2028, and raising full-year revenue estimates to $16.8 billion for 2027 and $23.9 billion for 2028.
4. Risks and Analyst Dispersion
Earnings-per-share estimates for fiscal 2029 vary widely from $4.38 to $11.87, indicating uncertainty in long-term profitability; past market shocks have pushed the stock down as much as 66% from its highs, underscoring potential volatility.
